Podiatrists in Callahan, FL Accepting Medicare
6 Podiatrists found. Showing 1 - 6
 John Leon Clark, DPM Podiatrist - Foot & Ankle Surgery Medicare: Not Enrolled in Medicare Practice Location: 542067 Us Highway 1, Callahan, FL 32011 Phone: 904-879-2552 Fax: 904-879-6360 |
Steven K Greenhut, DPM Podiatrist - Foot Surgery Medicare: Not Enrolled in Medicare Practice Location: 542067 Us Hwy 1, Callahan, FL 32011 Phone: 904-879-2552 Fax: 904-879-6360 |
Michael L Friedman, DPM Podiatrist - Foot Surgery Medicare: Not Enrolled in Medicare Practice Location: 542067 Us Hwy 1, Callahan, FL 32011 Phone: 904-879-2552 Fax: 904-879-6360 |
 Callahan Foot & Ankle Clinic Podiatrist Medicare: Medicare Enrolled Practice Location: 542067 Us Highway 1, Callahan, FL 32011 Phone: 904-879-2552 Fax: 904-879-6360 |
Dr. Chester Howard Penn, D.P.M. Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 542067 Us Highway 1, Callahan, FL 32011 Phone: 904-879-2552 Fax: 904-879-6360 |
 Cara A Lapkowicz, DPM Podiatrist - Foot Surgery Medicare: Accepting Medicare Assignments Practice Location: 542067 Us Hwy 1, Callahan, FL 32011 Phone: 904-879-2552 Fax: 904-879-6360 |
News Archive
Prevenar 13: Immunogenic and well tolerated in young children previously vaccinated with Prevenar
According to results from a Phase III safety and immunogenicity study presented today, Prevenar 13 (Pneumococcal polysaccharide conjugate vaccine, [13-valent, adsorbed]) was shown to be immunogenic and generally well tolerated in healthy young children who had received at least three prior doses of Prevenar (Pneumococcal Saccharide Conjugated Vaccine, Adsorbed). These data were presented today at the 7th International Symposium on Pneumococci and Pneumococcal Diseases (ISPPD) in Tel Aviv, Israel.
Dendreon reports $125.7 million net loss for first-quarter 2010
Dendreon Corporation today reported results for the quarter ended March 31, 2010. Revenue for the quarter ended March 31, 2010 was $21,000 compared to $30,000 for the quarter ended March 31, 2009.
Study investigates pilot VBBD program to improve adherence to diabetes medications
A recent study led by MedImpact Healthcare Systems, Inc. investigated a pilot Value-Based Benefit Design program to improve adherence to diabetes medications. The study found that a VBBD program that reduced copayments for diabetes medications by 36 percent reduced the number of non-adherent patients by 30 percent.
Treating soft tissue sarcoma with shorter radiation treatment found to be safe, effective
A new study led by researchers at the UCLA Jonsson Comprehensive Cancer Center found that treating soft tissue sarcoma with radiation over a significantly shorter period of time is safe, and likely just as effective, as a much longer conventional course of treatment.
› Verified 8 days ago